CalciMedica
CALC
27 hedge funds and large institutions have $5.97M invested in CalciMedica in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.
2,400% more call options, than puts
Call options by funds: $75K | Put options by funds: $3K
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
8% more funds holding
Funds holding: 25 → 27 (+2)
5% less capital invested
Capital invested by funds: $6.27M → $5.97M (-$292K)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Top Buyers
| 1 |
Belvedere Trading
Chicago,
Illinois
|
+$4.25K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.14K |
| 3 |
Morgan Stanley
New York
|
+$1.12K |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$796 |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$505 |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$35.6K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$17.7K |
| 3 |
First Manhattan
New York
|
-$16.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14.7K |
| 5 |
Jane Street
New York
|
-$11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Jane Street
New York
| – | -$11K | -818 | Closed |
|
27
Simplex Trading
Chicago,
Illinois
| – | -$763 | -68 | -99% |
|
28
BNP Paribas Financial Markets
Paris,
France
| – | -$107 | -8 | Closed |
|
CALC Hedge Fund Activity: Q4 2022 in Review
27 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q4 2022, worth a combined $5.97M — down 4.7% from $6.27M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CALC positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 8 trimmed.
The largest buyer was Belvedere Trading, opening a new position worth an estimated $4.25K. The largest seller was Renaissance Technologies, cutting an estimated $35.6K.
- 27 institutional investors held CalciMedica (CALC) as of Q4 2022, up from 25 in Q3 2022.
- Funds reported $5.97M of CalciMedica stock for Q4 2022, down 4.7% quarter-over-quarter.
- 5 funds opened new CalciMedica positions in Q4 2022 and 3 closed out, a net change of +2 holders.
- The largest CalciMedica buyer in Q4 2022 was Belvedere Trading, an estimated $4.25K added.
- The largest CalciMedica seller in Q4 2022 was Renaissance Technologies, an estimated $35.6K sold.
Based on aggregated 13F filings for Q4 2022.